Duration of viral shedding and culture positivity with post-vaccination breakthrough delta variant infections
Mark J. Siedner(Harvard University), Jonathan Z. Li(Brigham and Women's Hospital), Chana A. Sacks(Harvard University), Grace Chamberlin(Harvard University), Crystal M. North(Harvard University), Jonathan Luu(Harvard University), Robert H. Goldstein(Harvard University), Jacob E. Lemieux(Harvard University), Surabhi Iyer(Massachusetts General Hospital), James Regan(Brigham and Women's Hospital), James P. Flynn(Brigham and Women's Hospital), Amy K. Barczak(Harvard University), Julie Boucau(Harvard University), Zahra Reynolds(Massachusetts General Hospital), Manish C. Choudhary(Brigham and Women's Hospital), Rebecca F. Gilbert(Massachusetts General Hospital), Tammy D. Vyas(Massachusetts General Hospital), Sebastien Haneuse(Harvard University), Jatin M. Vyas(Broad Institute), Rockib Uddin(Massachusetts General Hospital)
Cited by 5
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801